Yi Zheng

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling

Yi Zheng, Meng-Wei Zhuang, Lulu Han et al. · Signal Transduction and Targeted Therapy · 2020 · 305 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

SARS‐CoV‐2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG‐I/MDA‐5–MAVS, TLR3–TRIF, and cGAS–STING signaling pathways

Lulu Han, Meng‐Wei Zhuang, Jian Deng et al. · Journal of Medical Virology · 2021 · 244 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules

Yi Zheng, Jian Deng, Lulu Han et al. · Signal Transduction and Targeted Therapy · 2022 · 178 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

USP5 attenuates NLRP3 inflammasome activation by promoting autophagic degradation of NLRP3

Baoshan Cai, Jian Zhao, Yuling Zhang et al. · Autophagy · 2021 · 142 citations · Full text

Life Sciences, Cell Biology, Immunology +17

USP18 positively regulates innate antiviral immunity by promoting K63-linked polyubiquitination of MAVS

Jinxiu Hou, Lulu Han, Ze Zhao et al. · Nature Communications · 2021 · 120 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17